Multicentre assessment of interactive 3D holograms for enhanced preoperative planning for colorectal liver metastasis resection.
Authors
Affiliations (23)
Affiliations (23)
- Department for General and Transplantation Surgery, University Hospital Tübingen, Tübingen, Germany.
- Department of HPB and Transplant, St James's University Hospital, Leeds, UK; Leeds Institute of Medical Research, University of Leeds, Leeds, UK. Electronic address: [email protected].
- Department of General and Visceral Surgery, Barmherzige Brüder, Munich, Germany.
- Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.
- Department of General, Visceral, and Paediatric Surgery, University Medical Centre Göttingen, Göttingen, Germany.
- Department of General, Visceral, Cancer and Transplant Surgery, Faculty of Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.
- Department of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.
- Department of HPB and Transplant, St James's University Hospital, Leeds, UK.
- Nottingham Digestive Diseases Centre, Division of Translational Medical Sciences, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, UK.
- Royal Surrey County Hospital NHS Foundation Trust, Guilford, UK.
- The Intervention Centre, Department of HPB Surgery, Oslo University, Oslo, Norway.
- Department of HPB Surgery, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
- Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK.
- Department of General and Visceral Surgery, Hepatobiliary Center, Kepler University Hospital GmbH, Johannes Kepler University, Linz, Austria.
- Department of HPB Surgery, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
- Department of General & Visceral Surgery, Agatharied Hospital, Hausha, Germany.
- Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- Department of HPB Surgery, King's College Hospital NHS Foundation Trust, London, UK.
- Department of Hepatobiliary and General Surgery, Humanitas University, Milan, Italy.
- Department of General, Visceral and Transplant Surgery, Münster University Hospital, Münster, Germany.
- Department of Digestive, Oncological and Metabolic Surgery, Institut Mutualiste Montsouris, Paris, France.
- Department of HPB Surgery, Amsterdam UMC, Amsterdam, Netherlands.
- Department of HPB and Transplant, St James's University Hospital, Leeds, UK; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Abstract
Surgical planning for colorectal liver metastasis (CRLM) is crucial for achieving curative resection. The advent of artificial intelligence and automatic image segmentation has made 3D holograms readily available for surgical planning. Conventional patient imaging can now be converted into interactive 3D models and displayed in augmented reality (AR). This multicentre, observational study evaluated the impact of 3D visualisation on surgical planning for CRLM. 46 surgeons from 21 liver surgery centres in nine countries assessed eight complex CRLM cases. Each case included CT portal venous phase images and a 3D hologram displayed in AR, created using an automatic segmentation tool and quality assessed by radiologists. Surgeons completed four surveys covering experience, initial CT-based management, post-3D review management, and perceived benefit. Among the participants (33 consultants, 13 residents), 24% worked in centres performing 50-100 resections per year, and 70% in centres performing over 100 per year. The 3D holograms changed resectability assessments in 20% of cases (8% from inoperable to operable; 12% from operable to inoperable). Management decisions between neoadjuvant therapy and surgery changed in 21% of cases, and 22% of surgeons modified their surgical approach. Most surgeons (96%) found the technology easy to use, valuing it for complex cases (61%), tumour board discussions (83%), and teaching (98%). 3D holographic imaging can influence CRLM management decisions. The technology is acceptable to liver surgeons with multiple potential clinical applications. Prospective, randomised studies are needed to evaluate its clinical implementation and impact on patient outcomes.